Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

SHAREHOLDER ALERT: Investigation of ReWalk Robotics Announced by Holzer & Holzer, LLC

Holzer & Holzer,LLC
Posted on: 04 Oct 16

Holzer & Holzer, LLC is investigating whether certain statements made by ReWalk Robotics LTD (“ReWalk” or the “Company”) (NASDAQ: RWLK) complied with the federal securities laws. On May 10, 2016, ReWalk discussed issues with its ability to conduct an adequate postmarket surveillance plan for the Company’s product. A recently filed class action lawsuit against the Company alleges ReWalk improperly omitted information from its registration statement issued in connection with its initial public offering in September 2014.

If you purchased ReWalk common stock and suffered a loss on your investment, you are encouraged to contact Corey D. Holzer, Esq. at or Marshall P. Dees, Esq., at, or via toll-free telephone at (888) 508-6832, to discuss your legal rights.

Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.

View source version on

Business Wire

Last updated on: 04/10/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.